| Dr Ramakrishna R Kosuri, MD | |
|
11110 Medical Campus Rd, Suite 205, Hagerstown, MD 21742-6700 | |
| (301) 665-4950 | |
| (301) 665-4956 |
| Full Name | Dr Ramakrishna R Kosuri |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 36 Years |
| Location | 11110 Medical Campus Rd, Hagerstown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588624498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | D0059084 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center | Hagerstown, MD | Hospital |
| Frederick Health Hospital | Frederick, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Practices Of Antietam, Llc | 2567353865 | 184 |
News Archive
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Immunoglobulin E (IgE) is the main actor in the drama of allergy. The biological role of IgE in the immune response of an organism and the lack of control leading to allergy is the research topic of Gernot Achatz, Molekular Biology, University of Salzburg. At the 2nd European Congress of Immunology ECI 2009 held in Berlin the scientist presents new data revealing the evolution of IgE.
Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.
A novel way to image the entire brain's glymphatic pathway, a dynamic process that clears waste and solutes from the brain that otherwise might build-up and contribute to the development of Alzheimer's disease, may provide the basis for a new strategy to evaluate disease susceptibility, according to a research paper published online in The Journal of Clinical Investigation.
Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer.
› Verified 6 days ago
| Entity Name | Medical Practices Of Antietam, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558430843 PECOS PAC ID: 2567353865 Enrollment ID: O20040324001019 |
News Archive
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Immunoglobulin E (IgE) is the main actor in the drama of allergy. The biological role of IgE in the immune response of an organism and the lack of control leading to allergy is the research topic of Gernot Achatz, Molekular Biology, University of Salzburg. At the 2nd European Congress of Immunology ECI 2009 held in Berlin the scientist presents new data revealing the evolution of IgE.
Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.
A novel way to image the entire brain's glymphatic pathway, a dynamic process that clears waste and solutes from the brain that otherwise might build-up and contribute to the development of Alzheimer's disease, may provide the basis for a new strategy to evaluate disease susceptibility, according to a research paper published online in The Journal of Clinical Investigation.
Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer.
› Verified 6 days ago
| Entity Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20130808000102 |
News Archive
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Immunoglobulin E (IgE) is the main actor in the drama of allergy. The biological role of IgE in the immune response of an organism and the lack of control leading to allergy is the research topic of Gernot Achatz, Molekular Biology, University of Salzburg. At the 2nd European Congress of Immunology ECI 2009 held in Berlin the scientist presents new data revealing the evolution of IgE.
Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.
A novel way to image the entire brain's glymphatic pathway, a dynamic process that clears waste and solutes from the brain that otherwise might build-up and contribute to the development of Alzheimer's disease, may provide the basis for a new strategy to evaluate disease susceptibility, according to a research paper published online in The Journal of Clinical Investigation.
Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ramakrishna R Kosuri, MD 11110 Medical Campus Rd, Suite 205, Hagerstown, MD 21742-6700 Ph: (301) 665-4950 | Dr Ramakrishna R Kosuri, MD 11110 Medical Campus Rd, Suite 205, Hagerstown, MD 21742-6700 Ph: (301) 665-4950 |
News Archive
Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes.
Immunoglobulin E (IgE) is the main actor in the drama of allergy. The biological role of IgE in the immune response of an organism and the lack of control leading to allergy is the research topic of Gernot Achatz, Molekular Biology, University of Salzburg. At the 2nd European Congress of Immunology ECI 2009 held in Berlin the scientist presents new data revealing the evolution of IgE.
Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.
A novel way to image the entire brain's glymphatic pathway, a dynamic process that clears waste and solutes from the brain that otherwise might build-up and contribute to the development of Alzheimer's disease, may provide the basis for a new strategy to evaluate disease susceptibility, according to a research paper published online in The Journal of Clinical Investigation.
Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer.
› Verified 6 days ago
Dr. Cheryl Lourdes Mejia, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1150 Professional Ct, Suite P, Hagerstown, MD 21740 Phone: 301-665-9696 Fax: 240-420-5715 | |
Ngozi Juliet Efobi, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1150 Professional Ct, Suite B, Hagerstown, MD 21740 Phone: 301-797-4901 Fax: 301-797-4464 | |
Alyssa Faith Eisenhart, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1045 Maryland Ave, Hagerstown, MD 21740 Phone: 301-739-5437 | |
Christopher David Clark, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 13114 Pennsylvania Ave, Hagerstown, MD 21742 Phone: 301-800-7770 Fax: 301-800-7891 | |
Mark Joseph Yacyk, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 11110 Medical Campus Rd, Suite 205, Hagerstown, MD 21742 Phone: 301-665-4950 Fax: 301-665-4956 | |
Cynthia Brendle, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 19800 Tranquility Circle, Robinwood Campus, Hagerstown, MD 21742 Phone: 240-420-4133 |